Home/Filings/4/0001181431-10-005142
4//SEC Filing

Morris David J 4

Accession 0001181431-10-005142

CIK 0001295976other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 3:39 PM ET

Size

19.6 KB

Accession

0001181431-10-005142

Insider Transaction Report

Form 4
Period: 2010-01-27
Morris David J
Sr. V.P. Finance, CFO
Transactions
  • Sale

    Common Stock

    2010-01-27$13.00/sh44,427$577,55192,395 total
  • Other

    Employee Stock Option

    2010-01-27120,9320 total
    Exercise: $5.28Exp: 2019-04-13Common Stock (120,932 underlying)
  • Other

    Employee Stock Option

    2010-01-27+120,932120,932 total
    Exercise: $5.28Exp: 2019-04-13Common Stock (120,932 underlying)
  • Conversion

    Common Stock

    2010-01-27+117,085136,822 total
  • Conversion

    Series B Preferred Stock

    2010-01-2719,7370 total
    Common Stock (19,737 underlying)
  • Award

    Employee Stock Option

    2010-01-27+28,22528,225 total
    Exercise: $11.45Exp: 2020-01-27Common Stock (28,225 underlying)
  • Conversion

    Common Stock

    2010-01-27+19,73719,737 total
  • Conversion

    Common Stock

    2010-01-27117,0850 total
    Common Stock (117,085 underlying)
Footnotes (5)
  • [F1]Series B Preferred Stock of Cellu Parent Corporation was converted into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation was merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
  • [F2]Reporting person was granted shares of Restricted Stock in Cellu Parent Corporation on August 6, 2007, of which 50% had vested. Pursuant to the terms of the reorganization transactions that were consummated in connection with the Issuer's initial public offering and upon the closing of the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation Common Stock was exchanged for fully vested shares of Issuer Common Stock.
  • [F3]Reporting person held an option to purchase shares of Common Stock in Cellu Parent Corporation. Pursuant to the terms of the reorganization transactions that were consummated in connection with the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation options were exchanged for options to purchase Issuer Common Stock.
  • [F4]On the date of the exchange, options to purchase 39,267 shares became fully vested and options for the remaining shares will vest as to 33.33% of the shares each year beginning on the first anniversary date of the closing of the Issuer's initial public offering.
  • [F5]Stock option grant under the Issuer's 2010 Equity Compensation Plan. Vests in four equal installments annually beginning on January 27, 2011.

Issuer

Cellu Tissue Holdings, Inc.

CIK 0001295976

Entity typeother

Related Parties

1
  • filerCIK 0001306780

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 3:39 PM ET
Size
19.6 KB